Sanofi

ANZEMET

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / ANZEMET – Q0180

Manufacturer:

Sanofi

Name:

ANZEMET

HCPCS Code Descriptor:

Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen

Category:

Q Code

HCPCS:

Q0180

NDC(s):

00088-1202-05, 00088-1203-05,

Primary Type:

Oncology-Anti-Emetic

Generic Status:

Route of Administration:

Oral

About:

ANZEMET is an Oncology-Anti-Emetic drug manufactured by Sanofi and administered via the Oral route of administration. The Q Code: Q0180 is aligned to the drug ANZEMET.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

4/1/98

HCPCS Effective Date:

4/1/98

HCPCS Short Description:

Dolasetron mesylate oral

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found